Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex A Henneman

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Proteomics|November 8, 2023
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomicsHanneke van der Wijngaart, Robin Beekhof, Jaco C Knol, et al.
Molecular Oncology|April 23, 2024
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenuesAndrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, et al.
Molecular & Cellular Proteomics : MCP|July 21, 2022
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB PhosphoserinesIris E Glykofridis, Alex A Henneman, Jesper A Balk, et al.
Scientific Reports|May 27, 2018
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidansFrank Fleurbaaij, Alex A Henneman, Jeroen Corver, et al.
Frontiers in Immunology|May 10, 2021
Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked Sialic Acid Ligand BindingRui-Jún Eveline Li, Aram de Haas, Ernesto Rodríguez, et al.
Cell Reports|June 3, 2023
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinomaAndrea Vallés-Martí, Giulia Mantini, Paul Manoukian, et al.
Circulation Research|July 21, 2023
EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic CardiomyopathySila Algül, Maike Schuldt, Emmy Manders, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2020
Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell LinesCarolien van Alphen, Jacqueline Cloos, Robin Beekhof, et al.
Nature Communications|February 26, 2022
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategiesValentina Cordo', Mariska T Meijer, Rico Hagelaar, et al.
Molecular Systems Biology|May 26, 2019
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinasesRobin Beekhof, Carolien van Alphen, Alex A Henneman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Proteomics|November 8, 2023
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomicsHanneke van der Wijngaart, Robin Beekhof, Jaco C Knol, et al.
Molecular Oncology|April 23, 2024
Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenuesAndrea Vallés-Martí, Richard R de Goeij-de Haas, Alex A Henneman, et al.
Molecular & Cellular Proteomics : MCP|July 21, 2022
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB PhosphoserinesIris E Glykofridis, Alex A Henneman, Jesper A Balk, et al.
Scientific Reports|May 27, 2018
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidansFrank Fleurbaaij, Alex A Henneman, Jeroen Corver, et al.
Frontiers in Immunology|May 10, 2021
Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked Sialic Acid Ligand BindingRui-Jún Eveline Li, Aram de Haas, Ernesto Rodríguez, et al.
Cell Reports|June 3, 2023
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinomaAndrea Vallés-Martí, Giulia Mantini, Paul Manoukian, et al.
Circulation Research|July 21, 2023
EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic CardiomyopathySila Algül, Maike Schuldt, Emmy Manders, et al.
Molecular & Cellular Proteomics : MCP|February 28, 2020
Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell LinesCarolien van Alphen, Jacqueline Cloos, Robin Beekhof, et al.
Nature Communications|February 26, 2022
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategiesValentina Cordo', Mariska T Meijer, Rico Hagelaar, et al.
Molecular Systems Biology|May 26, 2019
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinasesRobin Beekhof, Carolien van Alphen, Alex A Henneman, et al.
Pageof 3